固生堂拟全购大中堂 扩新加坡市场份额

AASTOCKS
2025.11.16 12:16

GUSHENGTANG (02273.HK) announced that its subsidiary Gushengtang Singapore has entered into an equity transfer agreement to acquire 100% equity of Dazhongtang, which mainly engages in providing traditional Chinese medicine services and retail of pharmaceuticals in Singapore. The price will be determined after negotiation between both parties. If the acquisition is successfully completed, the group will add 14 traditional Chinese medicine clinics to its operations

来源：AASTOCKS 本文版权归属原作者/机构所有。
当前内容仅代表作者观点，与本平台立场无关。内容仅供投资者参考，亦不构成任何投资建议。如对本平台提供的内容服务有任何疑问或建议，请联系我们。